Al18F-NOTA-FAPI PET/CT Imaging for Malignant Tumors (NCT05749302)
Summary
ClinicalTrials.gov registry entry NCT05749302 for a Phase 3 interventional study evaluating Al18F-NOTA-FAPI PET/CT imaging in participants with malignant tumors. The trial is registered on ClinicalTrials.gov, operated by the National Library of Medicine under NIH, and classified as Phase 3.
About this source
GovPing monitors ClinicalTrials.gov - Phase 3 Oncology Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.
What changed
ClinicalTrials.gov registry entry for Phase 3 trial NCT05749302 evaluating Al18F-NOTA-FAPI PET/CT imaging as a diagnostic tool for malignant tumors. The registration provides study metadata including trial identifier, condition (cancer), phase classification (Phase 3), and sort parameters. The Al18F-NOTA-FAPI radiopharmaceutical targets fibroblast activation protein (FAP) for PET/CT imaging of tumors.
Affected parties include clinical investigators conducting oncology imaging trials, sponsors of radiopharmaceutical trials, and healthcare institutions conducting Phase 3 cancer imaging studies. This registration establishes a public record of the trial but imposes no compliance obligations beyond standard clinical trial registration requirements.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov - Phase 3 Oncology Trials
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov - Phase 3 Oncology Trials publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.